• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内递送方法的优化及其在小鼠生精小管中的应用。

Optimization of in vivo delivery methods and their applications in seminiferous tubules of mice.

作者信息

Dai Xinyuan, Wang Fangzhu, Wang Siting

机构信息

State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, 211166, China.

Gansu Provincial Maternal and Child Health Hospital, Gansu Provincial Central Hospital, Lanzhou, 730050, China.

出版信息

BMC Biotechnol. 2025 Aug 12;25(1):83. doi: 10.1186/s12896-025-01021-0.

DOI:10.1186/s12896-025-01021-0
PMID:40796825
Abstract

This study aims to explore and optimize the conditions for in vivo transfection and gene editing, emphasizing their potential applications in the treatment of infertility in mice. Our findings indicate that physical transfection can be effective in the dynamic fluid environment of mouse seminiferous tubules, with electroporation achieving transfection in multilayered cell tissues. Using the mTmG fluorescence reporter system, we visually assessed the efficiency of electroporation-based transfection and observed stable gene editing outcomes across different individuals. Additionally, we achieved effective transfection of germ cells in vivo for the clinical application of gene tools. We further investigated the impact of various delivery methods and molecular methods on transfection efficacy, revealing that RNP technology is adaptable and efficient in vivo, particularly in the context of treating hereditary diseases. We attempted to leverage gene editing techniques to address spermatogenesis blockage at different stages in Ythdc2-KO and CK137956-KO mice. While we did not succeed in rescuing spermatogenic blockage in Ythdc2 KO mice, the treatment of CK137956 KO mice yielded significant physiological responses. These results could be beneficial for the optimization of in vivo gene editing technologies for clinical applications.

摘要

本研究旨在探索和优化体内转染和基因编辑的条件,重点关注其在小鼠不孕症治疗中的潜在应用。我们的研究结果表明,物理转染在小鼠生精小管的动态流体环境中可能有效,电穿孔可在多层细胞组织中实现转染。使用mTmG荧光报告系统,我们直观地评估了基于电穿孔的转染效率,并观察到不同个体间稳定的基因编辑结果。此外,我们在体内实现了生殖细胞的有效转染,以用于基因工具的临床应用。我们进一步研究了各种递送方法和分子方法对转染效率的影响,发现核糖核蛋白(RNP)技术在体内具有适应性且高效,特别是在治疗遗传性疾病的背景下。我们试图利用基因编辑技术解决Ythdc2基因敲除(KO)和CK137956基因敲除小鼠不同阶段的精子发生阻滞问题。虽然我们未能成功挽救Ythdc2基因敲除小鼠的精子发生阻滞,但对CK137956基因敲除小鼠的治疗产生了显著的生理反应。这些结果可能有助于优化用于临床应用的体内基因编辑技术。

相似文献

1
Optimization of in vivo delivery methods and their applications in seminiferous tubules of mice.体内递送方法的优化及其在小鼠生精小管中的应用。
BMC Biotechnol. 2025 Aug 12;25(1):83. doi: 10.1186/s12896-025-01021-0.
2
Optimizing the delivery of CRISPR/Cas9 ribonucleoproteins for efficient genome editing in bovine embryos.优化CRISPR/Cas9核糖核蛋白的递送以实现牛胚胎的高效基因组编辑
Gene. 2025 Sep 20;966:149715. doi: 10.1016/j.gene.2025.149715. Epub 2025 Aug 6.
3
Computerized spermatogenesis staging (CSS) of mouse testis sections via quantitative histomorphological analysis.通过定量组织形态学分析对小鼠睾丸切片进行计算机化精子发生分期(CSS)。
Med Image Anal. 2021 May;70:101835. doi: 10.1016/j.media.2020.101835. Epub 2020 Oct 10.
4
Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis.用于CRISPR-Cas递送的类特洛伊木马载体:工程化细胞外囊泡和病毒样颗粒用于囊性纤维化的精准基因编辑
Hum Gene Ther. 2025 Apr 28. doi: 10.1089/hum.2024.258.
5
A solution for highly efficient electroporation of primary cytotoxic T lymphocytes.一种高效电穿孔原代细胞毒性 T 淋巴细胞的解决方案。
BMC Biotechnol. 2024 Mar 26;24(1):16. doi: 10.1186/s12896-024-00839-4.
6
An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesis.E3泛素连接酶RNF126在确保精子发生过程中减数分裂I完成方面的重要作用。
J Adv Res. 2025 Jul;73:231-245. doi: 10.1016/j.jare.2024.08.011. Epub 2024 Aug 12.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.体外基因编辑和细胞治疗遗传性酪氨酸血症 1 型。
Hepatol Commun. 2024 Apr 26;8(5). doi: 10.1097/HC9.0000000000000424. eCollection 2024 May 1.
9
A comparison of spermatogenesis between flies and men-conserved processes of male gamete production.果蝇与人类精子发生的比较——雄性配子产生的保守过程
Hum Reprod Update. 2025 Aug 13. doi: 10.1093/humupd/dmaf018.
10
Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation†.通过 CRISPR-Cas9 电穿孔对哺乳动物胚胎进行基因工程的简化流程†。
Biol Reprod. 2019 Jul 1;101(1):177-187. doi: 10.1093/biolre/ioz075.

本文引用的文献

1
YTHDC2 serves a distinct late role in spermatocytes during germ cell differentiation.YTHDC2 在精母细胞分化过程中具有独特的晚期功能。
Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2309548121. doi: 10.1073/pnas.2309548121. Epub 2024 Oct 8.
2
Past, present, and future of CRISPR genome editing technologies.CRISPR 基因组编辑技术的过去、现在和未来。
Cell. 2024 Feb 29;187(5):1076-1100. doi: 10.1016/j.cell.2024.01.042.
3
Drug delivery systems for CRISPR-based genome editors.用于基于CRISPR的基因组编辑工具的药物递送系统。
Nat Rev Drug Discov. 2023 Nov;22(11):875-894. doi: 10.1038/s41573-023-00762-x. Epub 2023 Sep 18.
4
Regulation of Miwi-mediated mRNA stabilization by Ck137956/Tssa is essential for male fertility.Ck137956/Tssa 通过调控 Miwi 介导的 mRNA 稳定对于雄性育性是必需的。
BMC Biol. 2023 Apr 17;21(1):89. doi: 10.1186/s12915-023-01589-z.
5
Understanding the genetics of human infertility.理解人类不孕不育的遗传学。
Science. 2023 Apr 14;380(6641):158-163. doi: 10.1126/science.adf7760. Epub 2023 Apr 13.
6
CRISPR/Cas9 therapeutics: progress and prospects.CRISPR/Cas9 疗法:进展与展望。
Signal Transduct Target Ther. 2023 Jan 16;8(1):36. doi: 10.1038/s41392-023-01309-7.
7
Advances in CRISPR therapeutics.CRISPR 疗法的进展。
Nat Rev Nephrol. 2023 Jan;19(1):9-22. doi: 10.1038/s41581-022-00636-2. Epub 2022 Oct 24.
8
Emerging roles and functional mechanisms of PIWI-interacting RNAs.PIWI相互作用RNA的新兴作用及功能机制
Nat Rev Mol Cell Biol. 2023 Feb;24(2):123-141. doi: 10.1038/s41580-022-00528-0. Epub 2022 Sep 14.
9
Therapeutic in vivo delivery of gene editing agents.基因编辑试剂的治疗性体内递送。
Cell. 2022 Jul 21;185(15):2806-2827. doi: 10.1016/j.cell.2022.03.045. Epub 2022 Jul 6.
10
Non-viral delivery of the CRISPR/Cas system: DNA RNA RNP.非病毒递送 CRISPR/Cas 系统:DNA、RNA、RNP。
Biomater Sci. 2022 Mar 2;10(5):1166-1192. doi: 10.1039/d1bm01658j.